“…CRP and ALB have been studied widely in various clinical settings and have been recognized as valuable prognostic markers for outcomes across various diseases, including sepsis, neoplasia, critical illness after intensive care unit (ICU) admission, and hospital-acquired acute kidney injury [28–32]. The CRP/ALB ratio, a combined index of the ALB and CRP levels, is known to be related more consistently to prognosis than is CRP or ALB alone, and it may accurately reflect the degree of inflammation or nutritional deficiency [13,14,33,34]. However, as the pathological mechanisms of ESLD (i.e., hepatic insufficiency and/or malnutrition) may negatively influence CRP and ALB production, cirrhotic patients have always been excluded from previous studies [13,14,25].…”